Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation

por Lammers, Rianne J. M., Hendriks, Jan C. M., Rodriguez Faba, O. Rodriguez Faba, Witjes, Wim P. J., Palou, Joan, Witjes, J. Alfred
Publicado 2015

The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate—a long-t...

por Dijkstra, Siebren, Witjes, Wim P. J., Roos, Erik P. M., Vijverberg, Peter L. M., Geboers, Arno D. H., Bruins, Jos L., Smits, Geert A. H. J., Vergunst, Henk, Mulders, Peter F. A.
Publicado 2016

Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NI...

por van Straten, Christine G.J.I., Caris, Christien, Grimm, Marc-Oliver, Colombel, Marc, Muilwijk, Tim, Martínez-Piñeiro, Luis, Babjuk, Marko M., Türkeri, Levent N., Palou, Joan, Patel, Anup, Bjartell, Anders S., Witjes, Wim P.J., van der Heijden, Antoine G., Kiemeney, Lambertus A.L.M.
Publicado 2023